Glenmark Pharma has target of Rs 250: Sukhani

Glenmark Pharma has target of Rs 250, says Sudarshan Sukhani, s2analytics.com.

Sukhani told CNBC-TV18, "Glenmark Pharma at Rs 300 has strong support and it is on the verge of breaking that support. The next target is Rs 250. For intraday traders obviously Rs 250 won't come in a day but it's not just Glenmark we have talked about many stocks and I have said that they are all on verge of breakdown or actually moving down. There is no sense in touching it before Rs 250, it's a short sell."
He further added, "Chambal Fertilisers is a sell but it's a low conviction sell, it's not a pattern breakdown. It went up, did not rally because of news about fertilizer, decontrol regulation etc. Because there are many other opportunities, I don